Postmarketing Adverse Event Reporting for Nonprescription Human Drug Products Marketed Without an Approved Application
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 17, 2009
February 3, 2025
95170478-4748-49e7-88f5-b582dc43e2ee
Related Documents
Expedited Programs for Serious Conditions | Drugs and Biologics
Guidance DocumentMay 30, 2014Center for Drug Evaluation and Research
CMC Postapproval Manufacturing Changes To Be Documented in Annual Reports
Guidance DocumentMarch 5, 2014Center for Drug Evaluation and Research
Radioactive Drug Research Committee: Human Research Without An Investigational New Drug Application
Guidance DocumentAugust 2, 2010Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.